Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)
Clinical trial NCT01480258 · COMPLETED
Trial details
- NCT number
- NCT01480258
- Sponsor
- MCM Vaccines B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-23
- Primary completion
- 2013-10-09
- Enrollment
- 1315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.